Evidium for Health Plans
Clinical foresight for financial stability and optimal member outcomes
Evidium models disease progression, treatment pathways and cost trajectories using transparent clinical logic. By forecasting how conditions are likely to evolve, health plans gain earlier visibility into financial risk and stronger confidence in performance management.
Clarity across clinical and financial decision-making
We help health plans across all lines of business
Anticipate high-cost oncology and specialty trajectories before high-cost claims materialize.
Improve pricing precision and reserve confidence through prospective disease modeling.
Strengthen risk adjustment integrity by modeling anticipated disease progression.
Manage specialty drug, cell and gene therapy exposure using transparent treatment sequencing logic.
Beyond retrospective risk analytics
Traditional models identify who was high cost. Evidium models how cost develops through forward-looking clinical trajectory forecasting.
Outcomes for health plans include:
- Improved member outcomes with improved Medical Loss Ratio (MLR) and Medical Cost Ratio (MCR) stability
- Earlier cost visibility for oncology, complex conditions and rare diseases
- Stronger reserve adequacy, reduced high-cost volatility and enhanced enterprise alignment
